Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health Study

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 492-497

  Kleber, Marcus E ^a   Renner, Wilfried ^b   Grammer, Tanja B ^c   Linsel Nitschke, Patrick ^d   Boehm, Bernhard O ^e   Winkelmann, Bernhard R ^f   Bugert, Peter ^g   Hoffmann, Michael M ^h   März, Winfried ^c,g  

^a LURIC Study Nonprofit LLC   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c SYNLAB ACADEMY   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f Cardiology Group   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Atherosclerosis; Cardiovascular disease; Myocardial infarction; rs599839; Sortilin

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID; GLYCEROL; LOW DENSITY LIPOPROTEIN; SORTILIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADOLESCENT; ADULT; AGED; CHOLESTEROL, LDL; CHROMOSOMES, HUMAN, PAIR 1; CORONARY DISEASE; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 77950023387     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.068     Document Type: Article

References (27)

1. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
2. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:443-453.
3. Willer C.J., Sanna S., Jackson A.U., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008, 40:161-169.
4. Kathiresan S., Voight B.F., Purcell S., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009.
5. Aulchenko Y.S., Ripatti S., Lindqvist I., et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009, 41:47-55.
6. Muendlein A., Geller-Rhomberg S., Saely C.H., et al. Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis. Atherosclerosis 2009.
7. Karvanen J., Silander K., Kee F., et al. The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts. Genet Epidemiol 2008.
8. Samani N.J., Braund P.S., Erdmann J., et al. The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol. J Mol Med 2008, 86:1233-1241.
9. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008, 40:189-197.
10. Sandhu M.S., Waterworth D.M., Debenham S.L., et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008, 371:483-491.
11. Wallace C., Newhouse S.J., Braund P., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82:139-149.
12. Schadt E.E., Molony C., Chudin E., et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008, 6:e107.
13. Kathiresan S., Willer C.J., Peloso G.M., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009, 41:56-65.
14. Sabatti C., Service S.K., Hartikainen A.L., et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009, 41:35-46.
15. Winkelmann B.R., Marz W., Boehm B.O., et al. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001, 2:S1-S73.
16. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975, 51:5-40.
17. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl. 1):S43-8.
18. Baumstark M.W., Kreutz W., Berg A., Frey I., Keul J. Structure of human low-density lipoprotein subfractions, determined by X-ray small-angle scattering. Biochim Biophys Acta 1990, 1037:48-57.
19. Nielsen M.S., Jacobsen C., Olivecrona G., Gliemann J., Petersen C.M. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 1999, 274:8832-8836.
20. Nilsson S.K., Christensen S., Raarup M.K., Ryan R.O., Nielsen M.S., Olivecrona G. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem 2008, 283:25920-25927.
21. Lamarche B., Tchernof A., Moorjani S., et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997, 95:69-75.
22. Slyper A.H. Low-density lipoprotein density and atherosclerosis. Unraveling the connection. JAMA 1994, 272:305-308.
23. Rapp R.J. Hypertriglyceridemia: a review beyond low-density lipoprotein. Cardiol Rev 2002, 10:163-172.
24. Sprecher D.L. Triglycerides as a risk factor for coronary artery disease. Am J Cardiol 1998, 82:49U-56U. [discussion 85U-86U].
25. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
26. Schunkert H., Gotz A., Braund P., et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008, 117:1675-1684.
27. Jarinova O., Stewart A.F., Roberts R., et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 2009.